Caris Life Sciences, Inc. is 1.1x more valuable than RadNet, Inc. by market capitalization ($4.93 B vs $4.60 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | RDNT | CAI |
|---|---|---|
| Market cap | $4.60 B | $4.93 B |
| US-listed rank | #1466 | #1401 |
| Revenue (latest FY) | $2.04B | $812.03M |
| Net income (latest FY) | -$18.65M | -$68.09M |
| Net margin | -0.9% | -8.4% |
| SEC filings | 1,345 | 102 |
Caris Life Sciences, Inc. is 1.1x more valuable than RadNet, Inc. by market capitalization ($4.93 B vs $4.60 B).
In their latest fiscal years, RadNet, Inc. reported $2.04B in revenue while Caris Life Sciences, Inc. reported $812.03M.
Full pages: RadNet, Inc. and Caris Life Sciences, Inc., or browse the full rankings.